• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins

tetano

Editor, Senior Moderator
Nat Commun


. 2024 Feb 12;15(1):850.
doi: 10.1038/s41467-024-44889-w. Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins

Daniëla Maria Hinke[SUP] 1 2 [/SUP], Ane Marie Anderson[SUP] 1 2 [/SUP], Kirankumar Katta[SUP] 2 [/SUP], Marlene Fyrstenberg Laursen[SUP] 2 [/SUP], Demo Yemane Tesfaye[SUP] 2 [/SUP], Ina Charlotta Werninghaus[SUP] 2 [/SUP], Davide Angeletti[SUP] 3 [/SUP], Gunnveig Grødeland[SUP] 1 2 [/SUP], Bjarne Bogen[SUP] 4 5 [/SUP], Ranveig Braathen[SUP] 6 7 [/SUP]



Affiliations
Abstract

Conserved epitopes shared between virus subtypes are often subdominant, making it difficult to induce broadly reactive antibodies by immunization. Here, we generate a plasmid DNA mix vaccine that encodes protein heterodimers with sixteen different influenza A virus hemagglutinins (HA) representing all HA subtypes except H1 (group 1) and H7 (group 2). Each single heterodimer expresses two different HA subtypes and is targeted to MHC class II on antigen presenting cells (APC). Female mice immunized with the plasmid mix produce antibodies not only against the 16 HA subtypes, but also against non-included H1 and H7. We demonstrate that individual antibody molecules cross-react between different HAs. Furthermore, the mix vaccine induces T cell responses to conserved HA epitopes. Immunized mice are partially protected against H1 viruses. The results show that application of valency-based immuno-selection to diversified antigens can be used to direct antibody responses towards conserved (subdominant) epitopes on viral antigens.


 
Back
Top Bottom